Evidence map›Paper›PMID 40632504›Full record

ArticleFunction (Oxford, England)2025

Sustained Accumulation of Molecular Clock Suppressors Period 1 and Period 2 Promotes C2C12 Myotube Atrophy Through an Autocrine-Mediated Mechanism With Relevance to Androgen Deprivation-Induced Limb Muscle Mass Loss.

Grant R Laskin, Jennifer L Steiner, Wayne A Ayers-Creech, Michael L Rossetti, Kirsten R Dunlap, Cynthia Vied, Choogon Lee, Nicholas P Greene, Dennis K Fix, Orlando Laitano and 2 more

Abstract read
In one paragraph

Article in Function (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Grant R LaskinDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Jennifer L SteinerDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Wayne A Ayers-CreechDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Michael L RossettiDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Kirsten R DunlapDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Cynthia ViedTranslational Science Laboratory, Florida State University College of Medicine, Tallahassee, FL 32306, USA.
Choogon LeeDepartment of Biomedical Sciences, Florida State University College of Medicine, 115 W Call Street, Tallahassee, FL 32304, USA.
Nicholas P GreeneDepartment of Health, Human Performance and Recreation, Cachexia Research Laboratory, Exercise Science Research Center, University of Arkansas, Fayetteville, AR 72701, USA.
Dennis K FixRecursion Pharmaceuticals, Salt Lake City, UT 84101, USA.
Orlando LaitanoDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA.
Kislay ParvatiyarDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Bradley S GordonDepartment of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.

Funding

A novel cell-based platform to study human circadian disordersR01GM147340 · NIGMS · FLORIDA STATE UNIVERSITY · PI LEE, CHOOGON · 2023 to 2024
$595k
Council on Research and Creativity at FSUFlorida State UniversityNIGMS NIH HHS R01 GM147340NIH HHS GM147340
6 · The paper itself

Abstract

Low testosterone in males (hypogonadism) is associated with limb muscle mass loss, yet the underlying mechanisms of muscle mass loss remain largely unknown. We previously showed androgen deprivation disrupted limb muscle molecular clock function, and the disruption coincided with elevated levels of the primary molecular clock suppressor, Period 2 (Per2). The purposes herein were to determine if PER2 overexpression leads to muscle atrophy and if preventing PER2 accumulation blunts limb muscle mass loss in response to androgen deprivation. Here, we identify Per2 as a negative regulator of muscle size. Overexpression of Per2 in differentiated C2C12 myotubes reduced myotube diameter, while deletion of Per2 in male mice partially preserved tibialis anterior (TA) mass following castration. The muscle-sparing effect of Per2 deletion in vivo was specific to the TA despite evidence of molecular clock disruption and mass loss in other muscles. Subsequently, we show overexpression of the other primary clock suppressor, Period 1 (Per1) also reduced myotube diameter in differentiated C2C12 myotubes. Mechanistically, both Per1 and Per2 overexpression in vitro induced muscle atrophy in part by an autocrine-mediated mechanism likely involving inflammation as their overexpression induced an inflammatory gene expression signature and increased cytokine/chemokine secretion. Moreover, incubation of C2C12 myotubes in the media conditioned from Per1 or Per2 overexpressing myotubes reduced myotube diameter. Several inflammatory genes identified in vitro were also altered in the limb muscles in response to androgen deprivation. These findings identify a previously unrecognized role for Per1/2 in regulating skeletal muscle mass with implications for muscle loss during hypogonadism.

Indexed as

AndrogensAutocrine CommunicationMuscle Fibers, SkeletalMuscle, SkeletalMuscular AtrophyPeriod Circadian ProteinsAnimalsCell LineMaleMiceMice, Inbred C57BLAndrogensPer1 protein, mousePer2 protein, mousePeriod Circadian Proteinscircadian rhythmhypogonadisminflammationRNA sequencing

Identifiers

PMID40632504
PMCPMC12316099

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.